Concordia International (CXRX) Misses Q3 EPS by 35c; Guidance Suspended
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
RBC Capital Downgrades Concordia Healthcare (CXRX) to Sector Perform
November 8, 2016 6:20 AM ESTRBC Capital downgraded Concordia Healthcare (NASDAQ: CXRX) from Outperform to Sector Perform with a price target of $2.50 (from $10.00) as the US Legacy business significantly underperformed largely due to pricing issues.
Analyst Douglas Miehm commented, "are downgrading Concordia to Sector perform as we believe risks are increasing materially and visibility is worsening. In... More
Canaccord Genuity Downgrades Concordia Healthcare (CXRX) to Sell
November 7, 2016 1:24 PM ESTCanaccord Genuity downgraded Concordia Healthcare (NASDAQ: CXRX) from Spec. Buy to Sell with a price target of $1.00.
For an analyst ratings summary and ratings history on Concordia Healthcare click here. For more ratings news on Concordia Healthcare click here.
Shares of Concordia Healthcare closed at $3.19 yesterday.
... More